Open Access Open Access  Restricted Access Subscription Access

Wine: An Alcoholic Beverage or a Wonder Drink

Gurmeet Singh Sarla

Abstract


Wine dependably discovers its way to the festival table. Wine has a long history of utilization as a medication making it the world's most established reported human made prescription. It has been suggested to be sterile for treating wounds, as a digestive aid, for lethargy, diarrhoea and as a pain relieving agent for agony from labour. Wine is made of grapes which are wealthy in numerous antioxidants including resveratrol, catechin, epicatechin and proanthocyanidins. In individuals with Type 2 diabetes mellitus and cardio vascular maladies, moderate consumption of wine is helpful. The danger of colonic, prostatic and breast malignancy can be diminished by devouring moderate measures of wine. Moderate drinking is viewed as sound and for ladies it is one glass a day and for men it is two glasses a day. Grapes and berries are preferable wellspring of resveratrol over red wine so eating these is more advantageous than drinking wine. In any case if you are going to drink, wine - exceptional notice to red wine- wellbeing impacts of which have been learned finally seems more advantageous as compared to other beverages. The point of this review article is to discuss about the aggregating proof that recommends the positive impact of wine utilization on human wellbeing.

Full Text:

PDF

References


Gotsis E., Anagnostis P., Mariolis A., Vlachou A., Katsiki N., Karagiannis A. Health Benefits of the Mediterranean Diet: An Update of Research over the Last 5 Years. Angiology. 2015; 66:304–318.

Artero A., Artero A., Tarin J.J., Cano A. The Impact of Moderate Wine Consumption on Health. Maturitas. 2015; 80:3–13.

St Leger A.S., Cochrane A.L., Moore F. Factors Associated with Cardiac Mortality in Developed Countries with Particular Reference to the Consumption of Wine. Lancet. 1979; 1:1017–1020.

Ranaivo HR, Diebolt M, Andriantsitohaina R. Wine polyphenols induce hypotension, and decrease cardiac reactivity and infarct size in rats: Involvement of nitric oxide. Br J Pharmacol. 2004; 142:671–8.

Cavallini G., Straniero S., Donati A., Bergamini E. Resveratrol requires red wine polyphenols for optimum antioxidant activity. J. Nutr. Health Aging. 2016; 20:540–545.

Teissedre P.L., Stockley C., Boban M., Ruf J.C., Alba M.O., Gambert P., Flesh M. The effects of wine consumption on cardiovascular disease and associated risk factors: A narrative review. OENO ONE. 2018; 52:67–79.

Klatsky A.L. Alcohol and cardiovascular diseases. Expert Rev. Cardiovasc. Ther. 2009; 7:499–506.

Del Pino-García R., González-SanJosé M.L., Rivero-Pérez M.D., García-Lomillo J., Muñiz P. The effects of heat treatment on the phenolic composition and antioxidant capacity of red wine pomace seasonings. Food Chem. 2017; 221:1723–1732.

Babal P, Danihel L, Černa A, Janega P, Andriantsitohaina R, Pechnova O. Red Wine polyphenols prevent endothelial damage induced by CCl4 administration. Physiol Res. 2006; 55:245–51.

Novakovic A, Gojkovic-Bukarica L, Peric M, Nezic D, Djukanovic B, Markovic-Lipkovski J, et al. The mechanism of endothelium independent relaxation induced by the wine polyphenol resveratrol in human internal mammary artery. J Pharmacol Sci. 2006; 101:85–90.

Formica JV, Regelson W. Review of the biology of Quercetin and related bioflavonoids. Food Chem Toxicol. 1995; 33:1061–80.

Inal M, Altinisik M, Bilgin MD. The effect of quercetin on renal ischemia and reperfusion injury in the rat. Cell Biochem Funct. 2002; 20:291–6.

Ikizler M, Erkasap N, Sadettin D, Tugrul K, Ziya K. Dietary polyphenol quercetin protects rat hearts during reperfusion: Enhanced antioxidant capacity with chronic treatment. Anadolu Kardiyol Derg. 2007; 7:404–10.

Slagter S.N., van Vliet-Ostaptchouk J.V., Vonk J.M., Boezen H.M., Dullaart R.P.F., Kobold A.C.M., Feskens E.J.M., van Beek A.P., van der Klauw M.M., Wolffenbuttel B.H.R. Combined Effects of Smoking and Alcohol on Metabolic Syndrome: The Lifelines Cohort Study. PLoS ONE. 2014; 9:e96406.

Vieira B.A., Luft V.C., Schmidt M.I., Chambless L.E., Chor D., Barreto S.M., Duncan B.B. Timing and Type of Alcohol Consumption and the Metabolic Syndrome—Elsa-Brasil. PLoS ONE. 2016; 11:e0163044.

Tresserra-Rimbau A., Medina-Remon A., Lamuela-Raventos R.M., Bullo M., Salas-Salvado J., Corella D., Fito M., Gea A., Gomez-Gracia E., Lapetra J., et al. Moderate Red Wine Consumption Is Associated with a Lower Prevalence of the Metabolic Syndrome in the Predimed Population. Br. J. Nutr. 2015; 113(Suppl. 2):S121–S130.

Fagherazzi G., Vilier A., Lajous M., Boutron-Ruault M.C., Balkau B., Clavel-Chapelon F., Bonnet F. Wine Consumption Throughout Life Is Inversely Associated with Type 2 Diabetes Risk, but Only in Overweight Individuals: Results from a Large Female French Cohort Study. Eur. J. Epidemiol. 2014; 29:831–839.

Chiva-Blanch G., Urpi-Sarda M., Ros E., Valderas-Martinez P., Casas R., Arranz S., Guillen M., Lamuela-Raventos R.M., Llorach R., Andres-Lacueva C., et al. Effects of Red Wine Polyphenols and Alcohol on Glucose Metabolism and the Lipid Profile: A Randomized Clinical Trial. Clin. Nutr. 2013; 32:200–206.

Dumesnil C., Dauchet L., Ruidavets J.B., Bingham A., Arveiler D., Ferrieres J., Ducimetiere P., Haas B., Bongard V., Wagner A., et al. Alcohol Consumption Patterns and Body Weight. Ann. Nutr. Metab. 2013; 62:91–97.

Klarich D.S., Brasser S.M., Hong M.Y. Moderate Alcohol Consumption and Colorectal Cancer Risk. Alcohol. Clin. Exp. Res. 2015; 39:1280–1291.

Kasicka-Jonderko A. Alcohol and the digestive system—Should it always be blamed? Prz. Gastroenterol. 2012; 7:264–275.

Barstad B., Sørensen T.I.A., Tjønneland A., Johansen D., Becker U., Andersen I.B., Grønbæk M. Intake of wine, beer and spirits and risk of gastric cancer. Eur. J. Cancer Prev. 2005; 14:239–243.

Godos J., Castellano S., Ray S., Grosso G., Galvano F. Dietary Polyphenol Intake and Depression: Results from the Mediterranean Healthy Eating, Lifestyle and Aging (Meal) Study. Molecules. 2018; 23:999.

Moreno-Indias I., Sanchez-Alcoholado L., Perez-Martinez P., Andres-Lacueva C., Cardona F., Tinahones F., Queipo-Ortuno M.I. Red Wine Polyphenols Modulate Fecal Microbiota and Reduce Markers of the Metabolic Syndrome in Obese Patients. Food Funct. 2016; 7:1775–1787.

Barroso E., Munoz-Gonzalez I., Jimenez E., Bartolome B., Moreno-Arribas M.V., Pelaez C., Martinez-Cuesta M.d., Requena T. Phylogenetic Profile of Gut Microbiota in Healthy Adults after Moderate Intake of Red Wine. Mol. Nutr. Food Res. 2017;61

Cuervo A., Reyes-Gavilan C.G., Ruas-Madiedo P., Lopez P., Suarez A., Gueimonde M., Gonzalez S. Red Wine Consumption Is Associated with Fecal Microbiota and Malondialdehyde in a Human Population. J. Am. Coll. Nutr. 2015; 34:135–141.

Rehm J., Mathers C., Popova S., Thavorncharoensap M., Teerawattananon Y., Patra J. Global Burden of Disease and Injury and Economic Cost Attributable to Alcohol Use and Alcohol-Use Disorders. Lancet. 2009; 373:2223–2233.

Fernandez-Sola J. Cardiovascular Risks and Benefits of Moderate and Heavy Alcohol Consumption. Nat. Rev. Cardiol. 2015; 12:576–587.

Giacosa A., Barale R., Bavaresco L., Gatenby P., Gerbi V., Janssens J., Morazzoni P. Cancer prevention in Europe: The Mediterranean diet as a protective choice. Eur. J. Cancer Prev. 2013; 22:90–95.

Levantesi G., Marfisi R., Mozaffarian D., Franzosi M.G., Maggioni A., Nicolosi G.L., Marchioli R. Wine consumption and risk of cardiovascular events after myocardial infarction: Results from the GISSI-Prevenzione trial. Int. J. Cardiol. 2013; 163:282–287.


Refbacks

  • There are currently no refbacks.